KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Basic and Clinical Health Sciences / 2021 / Cilt: 5 - Sayı: 2

THYROID HORMONE REPLACEMENT IN TOTAL THYROIDECTOMIZED PATIENTS: SYMPTOMATIC AND METABOLIC EFFECTS OF LEVOTHYROXINE MONOTHERAPY

Didem Dereli AKDENİZ
Mehmet Burak ÖZTOP
Sayfa
104–109
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We compared their thyroid hormone levels, glucose metabolism, lipid metabolism, their bodymass indexes, and their symptoms of thyroid problems before surgery and after one year of treatment ofL-thyroxine monotherapy.Results: the pre-op and post-op thyroid hormone levels were both in the normal range but the FT4 levelswere significantly higher in the 1st year results than pre-op results (1,42 ± 0,18 vs 1,29 ± 0,49 respectivelyP=0,005*) The FT3 levels also were in the normal range in pre and 1st year post-op but post-op FT3levels were significantly lower than pre-op levels (2,25 ± 0,27 vs 2,92 ± 0,49 retrospectively P

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose: In this study, we planned to investigate the effects of L-thyroxine monotherapy on totalthyroidectomized patients.
📊
Temel Bulgular & Veri:The main goal of our study is to evaluate if FT4 therapy is good enough notonly to maintain euthyroidism but also to provide a good quality of life and a balance in their metabolismMethods: In this study, we retrospectively evaluated 30 total thyroidectomized patients withoutmalignancy.
💡
Sonuç & Katkı:We compared their thyroid hormone levels, glucose metabolism, lipid metabolism, their bodymass indexes, and their symptoms of thyroid problems before surgery and after one year of treatment ofL-thyroxine monotherapy.Results: the pre-op and post-op thyroid hormone levels were both in the normal range but the FT4 levelswere significantly higher in the 1st year results than pre-op results (1,42 ± 0,18 vs 1,29 ± 0,49 respectivelyP=0,005*) The FT3 levels also were in the normal range in pre and 1st year post-op but post-op FT3levels were significantly lower than pre-op levels (2,25 ± 0,27 vs 2,92 ± 0,49 retrospectively P
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Purpose: In this study, we planned to investigate the effects of L-thyroxine monotherapy on totalthyroidectomized patients. The main goal of our study is to evaluate if FT4 therapy is good enough notonly to maintain euthyroidism but also to provide a good quality of life and a balance in their metabolismMethods: In this study, we retrospectively evaluated 30 total thyroidectomized patients withoutmalignancy. We compared their thyroid hormone levels, glucose metabolism, lipid metabolism, their bodymass indexes, and their symptoms of thyroid problems before surgery and after one year of treatment ofL-thyroxine monotherapy.Results: the pre-op and post-op thyroid hormone levels were both in the normal range but the FT4 levelswere significantly higher in the 1st year results than pre-op results (1,42 ± 0,18 vs 1,29 ± 0,49 respectivelyP=0,005*) The FT3 levels also were in the normal range in pre and 1st year post-op but post-op FT3levels were significantly lower than pre-op levels (2,25 ± 0,27 vs 2,92 ± 0,49 retrospectively P

🔖

Bu Makaleye Atıf Yap

AKDENİZ, D. D., ÖZTOP, M. B. (2022). THYROID HORMONE REPLACEMENT IN TOTAL THYROIDECTOMIZED PATIENTS: SYMPTOMATIC AND METABOLIC EFFECTS OF LEVOTHYROXINE MONOTHERAPY. Journal of Basic and Clinical Health Sciences, Cilt: 5 - Sayı: 2, 104–109. https://ajindex.com/articles/560480

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Perros P, Van Der Feltz-Cornelis C, Papini E, Nagy EV, Weetman AP, Hegedüs L. The Enigma Of Persistent Symptoms In Hypothyroid Patients Treated With Levothyroxine: A Narrative Review. Clin Endocrinol (Oxf) 2021; Mar: 30
  2. Jonklaas J, Bianco AC, Cappola AR, Celi FS, Fliers E, Heuer H, et al. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Eur Thyroid J. 2021 Mar; 10(1):10-38 3. Pirahanchi Y, Tariq MA, Jialal I. Physiology, Thyroid. 2021; Feb 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan
  3. Ito M., Miyauchi A., Hisakado M, Yoshioka W, Kudo T., Nishihara E, et al. Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients. Endocr J. 2019; Nov 28; 66(11):953-960
  4. Ito M, Miyauchi A, Hisakado M, Yoshioka W, Ide A, Kudo T, et al. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy. Thyroid 2017; Apr; 27(4):484-490
  5. Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 2008; 20;299(7):769-77
  6. Wolska A, Remaley AT. Measuring LDLcholesterol: what is the best way to do it? Curr Opin Cardiol. 2020; 35(4):405-411
  7. Billewicz WZ, Chapman RS, Crooks J, Day ME, Gossage J, et al. Statistical methods applied to the diagnosis of hypothyroidism. Q J Med 1969; 38: 255–266
  8. Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997; 82: 771–776
  9. Klein I, Trzepacz PT, Roberts M, Levey GS Symptom rating scale for assessing hyperthyroidism. Arch Intern Med 1988; 148:387– 390
  10. Ettleson MD, Bianco AC. Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone? J Clin Endocrinol Metab. 2020; 105(9):3090– 104
  11. Ross JS, Rohde S, Sangaralingham L, Brito JP, Choi L, Dutcher SK, et all. Generic and BrandName Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016. J. Clin. Endocrinol. Metab. 2019; 104(6):2305–2314
  12. Mitchell AL, Hickey B, Hickey JL, Pearce SHS. Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health 2009; 9:132
  13. Sawin CT, Herman T, Molitch ME, London MH,Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyro